Genome Editing the Blood-Brain Barrier with Sonoselective Focused Ultrasound

利用声选择性聚焦超声对血脑屏障进行基因组编辑

基本信息

  • 批准号:
    10403487
  • 负责人:
  • 金额:
    $ 59.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-15 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

The endothelium of the cerebral microcirculation is a critical component of the blood-brain barrier (BBB), which protects neural tissue through the presence of tight junctions between endothelial cells and efflux transporters that extrude many compounds back into the bloodstream. When developing drug delivery strategies for brain pathologies, these efflux transporters [e.g. multi drug resistance 1 (MDR1)] present a considerable challenge to effective drug delivery, as they limit the exposure of central nervous system (CNS) pathologies to many systemically administered agents. Meanwhile, nutrient transporters [e.g. glucose transporter 1 (GLUT1)] are critical for maintaining normal brain function. Indeed, genetic mutation(s) of GLUT1 can cause recurrent epileptic seizures, microcephaly, intellectual disability, spasticity, ataxia, and dysarthria. Given this central role in health and disease in the brain, the endothelium of the BBB represents a rich target for therapeutic genomic manipulation. In this proposal, we will engineer a platform technology capable of genome editing the BBB in a safe, endothelial cell-selective, and non-invasive manner, with precise loco-regional targeting provided by MR image-guidance. We call this approach, wherein very low pressure focused ultrasound is used to activate plasmid-coated microbubbles, “sonoselective” gene delivery. This is because, instead of employing a cell-specific promoter, ultrasound (i.e. “sono”) alone “selects” which cell type is transfected. Since endothelial cell-specific promoters are unnecessary, a vast array of genetic manipulations may be employed. In Aim 1, we will engineer acoustically-activated delivery agents that sonoselectively edit the genome of blood-brain barrier endothelium. This will entail testing CRISPR-Cas9 “nickase” plasmids with varying guide RNA (gRNA) pair sequences for their ability to sonoselectively delete GLUT1 and MDR1 from BBB endothelium. We will also test whether efficiency can be improved by incorporating plasmids into non-viral polymer nanoparticles (NPs) that are coupled covalently to MBs with non-immunogenic linkers. The most promising compositions will then be examined functionally using positron emission tomography (PET) [i.e. 18F-FDG for brain metabolism changes after GLUT1 deletion and (R)-[11C]verapamil for drug efflux changes after MDR1a deletion]. Further, single cell RNA sequencing (scRNAseq) will be used to assess the cell selectivity and efficacy of gene deletion. In Aim 2, we will augment the efficiency and control of sonoselective genome editing by rationally manipulating focused ultrasound parameters. We will test whether increasing FUS burst duration improves plasmid delivery and subsequent gene (GLUT1 and MDR1) deletion efficiency. We will also test whether we can control sonoselective genome editing using a feedback control system based on acoustic emissions. Once completed, we will have established a safe, non-invasive, MR image-guided, platform for genome editing of endothelium in the BBB. We submit that such an approach will have multiple applications in pre-clinical neuroscience research and considerable potential as a therapeutic approach to treating many diseases of the CNS.
脑微循环内皮是血脑屏障(BBB)的重要组成部分, 其通过内皮细胞之间的紧密连接和外排保护神经组织 将许多化合物排回血液的转运蛋白。当开发药物输送策略时, 对于脑病理,这些外排转运蛋白[例如多药耐药1(MDR 1)]呈现出相当大的 有效药物递送的挑战,因为它们限制了中枢神经系统(CNS)病变暴露于 许多全身施用的药剂。同时,营养转运蛋白[例如葡萄糖转运蛋白1(GLUT 1)] 对维持正常的大脑功能至关重要事实上,GLUT 1的基因突变可以导致复发性 癫痫发作、小头畸形、智力残疾、痉挛状态、共济失调和构音障碍。 考虑到在大脑健康和疾病中的这种中心作用,BBB的内皮代表了丰富的脑血管内皮细胞。 用于治疗性基因组操作靶点。在本提案中,我们将设计一种平台技术, 以安全、内皮细胞选择性和非侵入性的方式对BBB进行基因组编辑, 通过MR图像引导提供靶向。我们称之为超低压聚焦超声 用于激活质粒包被的微泡,“声选择性”基因递送。这是因为, 使用细胞特异性启动子,单独的超声波(即“Sono”)“选择”转染的细胞类型。以来 虽然内皮细胞特异性启动子是不必要的,但是可以采用大量的遗传操作。 在Aim 1中,我们将设计声激活递送剂,其声选择性地编辑 血脑屏障内皮这将需要用不同的指导RNA测试CRISPR-Cas9“切口酶”质粒 针对它们从BBB内皮中声选择性地缺失GLUT 1和MDR 1的能力,对gRNA配对序列进行了研究。我们 还将测试是否可以通过将质粒并入非病毒聚合物纳米颗粒来提高效率 (NPs)其用非免疫原性接头共价偶联至MB。最有前途的组合物将 然后使用正电子发射断层扫描(PET)[即用于脑代谢的18F-FDG]进行功能检查 GLUT 1缺失后的变化和(R)-[11 C]维拉帕米用于MDR 1a缺失后的药物外排变化]。此外,本发明还 将使用单细胞RNA测序(scRNAseq)来评估细胞选择性和基因缺失的功效。 在目标2中,我们将通过合理地操纵基因组,提高声选择性基因组编辑的效率和控制。 聚焦超声参数。我们将测试增加FUS爆发持续时间是否改善质粒递送 以及随后的基因(GLUT 1和MDR 1)缺失效率。我们还将测试我们是否能够控制 使用基于声发射的反馈控制系统进行声选择性基因组编辑。一旦完成, 我们将建立一个安全、非侵入性、MR图像引导的内皮细胞基因组编辑平台, 的BBB。我们认为,这种方法将在临床前神经科学研究中有多种应用 并且作为治疗许多CNS疾病的治疗方法具有相当大的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard J. Price其他文献

A novel ‘bottom-up’ synthesis of few- and multi-layer graphene platelets with partial oxidation via cavitation
  • DOI:
    10.1016/j.ultsonch.2019.03.020
  • 发表时间:
    2019-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Richard J. Price;Paul I. Ladislaus;Graham C. Smith;Trevor J. Davies
  • 通讯作者:
    Trevor J. Davies
Dynamics of Adult Axin2 Cell Lineage Integration in Granule Neurons of the Dentate Gyrus
齿状回颗粒神经元中成人 Axin2 细胞谱系整合的动态
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Khadijeh A. Sharifi;Faraz Farzad;Sauson Soldozy;Richard J. Price;M. Y. S. Kalani;P. Tvrdik
  • 通讯作者:
    P. Tvrdik
Focused ultrasound augments the delivery and penetration of model therapeutics into cerebral cavernous malformations
聚焦超声增强了模型治疗药物向脑海绵状血管畸形的递送和渗透。
  • DOI:
    10.1016/j.jconrel.2025.113861
  • 发表时间:
    2025-07-10
  • 期刊:
  • 影响因子:
    11.500
  • 作者:
    Delaney G. Fisher;Matthew R. Hoch;Catherine M. Gorick;Claire Huchthausen;Victoria R. Breza;Khadijeh A. Sharifi;Petr Tvrdik;G. Wilson Miller;Richard J. Price
  • 通讯作者:
    Richard J. Price
Focused ultrasound-microbubble treatment arrests the growth and formation of cerebral cavernous malformations
聚焦超声微泡治疗可阻止脑海绵状畸形的生长和形成
  • DOI:
    10.1038/s41551-025-01390-z
  • 发表时间:
    2025-05-13
  • 期刊:
  • 影响因子:
    26.600
  • 作者:
    Delaney G. Fisher;Tanya Cruz;Matthew R. Hoch;Khadijeh A. Sharifi;Ishaan M. Shah;Catherine M. Gorick;Victoria R. Breza;Anna C. Debski;Joshua D. Samuels;Jason P. Sheehan;David Schlesinger;David Moore;James W. Mandell;John R. Lukens;G. Wilson Miller;Petr Tvrdik;Richard J. Price
  • 通讯作者:
    Richard J. Price

Richard J. Price的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard J. Price', 18)}}的其他基金

Genome Editing the Blood-Brain Barrier with Sonoselective Focused Ultrasound
利用声选择性聚焦超声对血脑屏障进行基因组编辑
  • 批准号:
    10554403
  • 财政年份:
    2021
  • 资助金额:
    $ 59.34万
  • 项目类别:
ImmunoPET Assessment of anti-CD47 Immunotherapy Delivery to Glioblastoma with Focused Ultrasound
使用聚焦超声对胶质母细胞瘤进行抗 CD47 免疫治疗的免疫PET评估
  • 批准号:
    10041000
  • 财政年份:
    2020
  • 资助金额:
    $ 59.34万
  • 项目类别:
Innovative systemic gene therapy for treating Parkinson's disease
治疗帕金森病的创新系统基因疗法
  • 批准号:
    10164880
  • 财政年份:
    2019
  • 资助金额:
    $ 59.34万
  • 项目类别:
Innovative systemic gene therapy for treating Parkinson's disease
治疗帕金森病的创新系统基因疗法
  • 批准号:
    9927696
  • 财政年份:
    2019
  • 资助金额:
    $ 59.34万
  • 项目类别:
Innovative systemic gene therapy for treating Parkinson's disease
治疗帕金森病的创新系统基因疗法
  • 批准号:
    10394379
  • 财政年份:
    2019
  • 资助金额:
    $ 59.34万
  • 项目类别:
Innovative systemic gene therapy for treating Parkinson's disease
治疗帕金森病的创新系统基因疗法
  • 批准号:
    10609832
  • 财政年份:
    2019
  • 资助金额:
    $ 59.34万
  • 项目类别:
Endothelial DNA Methylation, Arteriogenic Capacity, and Shear Stress "Set-Point."
内皮 DNA 甲基化、动脉生成能力和剪切应力“设定点”。
  • 批准号:
    9311466
  • 财政年份:
    2017
  • 资助金额:
    $ 59.34万
  • 项目类别:
Application of Laser Speckle Flowmetry to Vascular Remodeling
激光散斑流量计在血管重塑中的应用
  • 批准号:
    8887112
  • 财政年份:
    2014
  • 资助金额:
    $ 59.34万
  • 项目类别:
Application of Laser Speckle Flowmetry to Vascular Remodeling
激光散斑流量计在血管重塑中的应用
  • 批准号:
    8765491
  • 财政年份:
    2014
  • 资助金额:
    $ 59.34万
  • 项目类别:
Bevacizumab Delivery to Glioblastoma with MR-Guided Focused Ultrasound
通过 MR 引导聚焦超声将贝伐珠单抗递送至胶质母细胞瘤
  • 批准号:
    8628120
  • 财政年份:
    2013
  • 资助金额:
    $ 59.34万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 59.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了